Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
ID: 356169Type: Posted
Overview

Buyer

Centers for Disease Control - NCEZID (HHS-CDC-NCEZID)

Award Range

$75K - $100K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation" through a cooperative agreement aimed at enhancing educational resources for families affected by CJD. The initiative seeks to improve awareness and provide critical information regarding CJD, a rare and incurable brain disorder, by developing educational materials, organizing a national conference, and establishing a helpline for caregivers. With a total funding amount of $500,000 available over five years, eligible applicants include state and local governments, educational institutions, nonprofits, and for-profit organizations, with proposals due by March 18, 2025. For further inquiries, interested parties can contact Tracey Ponder at TPonder@cdc.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) of the CDC has issued a Notice of Funding Opportunity to improve educational support for families affected by Creutzfeldt-Jakob Disease (CJD). The program seeks to enhance resources and raise awareness about CJD, which is a rare and incurable brain disorder. The funding, totaling $500,000 over five years, is intended for various educational initiatives, including developing fact sheets, organizing a national conference, and establishing a toll-free helpline for caregivers and families. Eligible applicants include state and local governments, educational institutions, nonprofits, and for-profit organizations. Proposals must be submitted by March 18, 2025. The evaluation process involves an initial review of responsiveness and a merit review based on criteria such as background, evaluation plans, and organizational capacity. The primary goal is to provide necessary support and information to those impacted by CJD, facilitate national surveillance for the disease, and raise public awareness concerning prion diseases to foster early detection of emerging forms. This opportunity reflects the CDC's commitment to addressing public health challenges and improving the quality of life for patients and their families.
    Similar Opportunities
    Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Increasing awareness and knowledge of Alpha-gal Syndrome in the United States." The primary objective of this funding opportunity is to enhance awareness, surveillance, and patient care related to Alpha-gal Syndrome (AGS), an emerging health condition that is not nationally notifiable. The grant seeks to support the formation of a professional association to disseminate knowledge about AGS, create educational resources for both the public and healthcare providers, and conduct enhanced public health surveillance, with a total estimated program funding of $10 million and awards ranging from $25,000 to $1 million. Interested applicants, including bona fide agents, must submit their applications electronically by May 1, 2026, with an anticipated award date of July 1, 2026. For further inquiries, applicants can contact Jeff Borchert at gqx1@cdc.gov or by phone at (970) 221-6494.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity for the continuation and expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). This cooperative agreement aims to enhance the collection of biospecimens and related data to support biomedical research on malignant mesothelioma, requiring applicants to have an established registry and tissue bank capable of functioning as a national resource. The initiative is crucial for advancing research into early disease markers, treatment modalities, and improving health outcomes for mesothelioma patients. The total estimated funding for this program is $5.5 million, with a ceiling and floor award amount of $1.1 million, and applications must be submitted electronically by March 23, 2026, with an anticipated award date of August 1, 2026. For further inquiries, interested parties can contact Bridgette Garrett at bgarrett@cdc.gov or by phone at 770-488-5715.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Eliminating Parasitic and Neglected Tropical Disease Threats to the United States," aimed at expanding its network of collaborating institutes for research and program support. The initiative seeks to achieve, accelerate, or maintain outcomes for the elimination or control of non-malaria parasitic threats and neglected tropical diseases that impact the health of Americans domestically and internationally. This cooperative agreement has an estimated total program funding of $10 million, with individual awards ranging from $500,000 to $666,667, and is expected to result in three awards. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 1, 2026, and awards anticipated by September 15, 2026.
    Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement the Urologic Management to Preserve Initial Renal Function Protocol for young children with myelomeningocele. The funding, which ranges from $166,428 to $488,571 per award, totals approximately $2,330,000, with an expected 19 awards to be made. Interested applicants, particularly small businesses, should note that applications are due by March 16, 2026, with an estimated award date of August 11, 2026; for further inquiries, contact Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov.
    US Travelers Health Research, Surveillance, and Outreach Network
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "US Travelers Health Research, Surveillance, and Outreach Network" through a cooperative agreement aimed at enhancing pre-travel health consultations for international travelers. The primary objectives are to increase the proportion of travelers receiving essential health advice and vaccinations before traveling to areas at risk for infectious diseases, thereby improving the quality of healthcare provided during these consultations. Given the rise in international travel and associated health risks, this initiative is crucial for educating travelers on preventive measures against illnesses such as yellow fever and malaria. The total funding available for this program is $3 million, with individual awards ranging from $450,000 to $600,000. Interested applicants, particularly for-profit organizations, should note that applications are due by March 1, 2026, with an estimated award date of September 15, 2026. For further inquiries, contact Amy Yang at AYang@cdc.gov or call 404-718-8836.
    Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering exploratory and developmental grants related to the World Trade Center Health Program (R21) to support research addressing diagnostic and treatment uncertainties for individuals affected by the 9/11 attacks. This funding opportunity aims to encourage innovative research projects that explore new areas of investigation, potentially leading to significant advancements in treatment effectiveness and diagnostic practices for those receiving monitoring and treatment under the James Zadroga 9/11 Health and Compensation Act. With an estimated total program funding of $30 million and an expected 60 awards, applicants can request funding ranging from $0 to $365,000. Interested parties should note that applications are due by 5:00 PM local time on February 12, 2026, and can direct inquiries to Dr. Eduardo O'Neill at 404-718-8844 or via email at fzt4@cdc.gov.